Updated May 2026 · Yahoo Finance & SEC EDGAR
AbbVie Inc.
AbbVie Inc. (ABBV) is a micro-cap stock with a market capitalization of $0, currently trading at $$202.71 as of 2026-05-08. Data is delayed; primary sourcing comes from Yahoo Finance for prices and SEC EDGAR for filings.
Key Statistics
Reading ABBV’s Recent Move
ABBV drifted modestly lower in the most recent session — -1.13%, closing at $202.71. Drift-sized moves on micro-cap names are statistically expected — the signal lives in cumulative weekly or monthly direction, not a single print.
A mid-range position is the neutral state — useful as a reference point, not as a signal.
AbbVie Inc. is a micro-cap at $0 in market capitalization. Micro-caps trade with low volume, wide bid-ask spreads, and limited analyst coverage; due diligence requires more direct work because secondary research is thin. The 3,310,347 session-volume figure runs below the typical daily turnover for this name.
Price History (1 Month)
| Date | Close |
|---|---|
| 2026-05-07 | $202.71 |
| 2026-05-06 | $205.03 |
| 2026-05-05 | $206.11 |
| 2026-05-04 | $208.16 |
| 2026-05-01 | $206.60 |
| 2026-04-30 | $211.32 |
| 2026-04-29 | $203.89 |
| 2026-04-28 | $197.69 |
| 2026-04-27 | $197.38 |
| 2026-04-24 | $198.71 |
| 2026-04-23 | $200.95 |
| 2026-04-22 | $200.50 |
| 2026-04-21 | $205.12 |
| 2026-04-20 | $203.71 |
| 2026-04-17 | $208.38 |
| 2026-04-16 | $208.99 |
| 2026-04-15 | $208.42 |
| 2026-04-14 | $210.26 |
| 2026-04-13 | $206.47 |
| 2026-04-10 | $207.94 |
| 2026-04-09 | $212.40 |
| 2026-04-08 | $211.59 |
How This Page Is Sourced
Pricing, volume, and 52-week range data come from Yahoo Finance, refreshed on the cadence the upstream feed updates. Company name and metadata are cross-referenced against the U.S. SEC EDGAR system, which is the authoritative source for public-company disclosures (10-K annual reports, 10-Q quarterly reports, 8-K material event filings). For macroeconomic context that affects equity valuations broadly — interest rates, inflation, GDP growth — see the indicators dashboard; for the editorial standards behind every page on the site, see the methodology page.
Quotes on this page are delayed and intended for informational use. ExecBolt is not a broker-dealer, registered investment advisor, or research firm. The site does not produce buy, sell, or hold ratings on any security and does not receive compensation from issuers. For verified real-time quotes and order execution, use a brokerage account; for company filings, go directly to SEC EDGAR.
Research ABBV
Frequently Asked Questions
What is the current price of ABBV?
AbbVie Inc. (ABBV) is trading at $202.71, down -1.13% from the prior close of $205.03. Volume in the most recent session was 3.3M. Last updated 2026-05-08; data is delayed and not real-time.
What is ABBV's market capitalization?
ABBV has a market capitalization of $0, classifying it as a micro-cap stock. Market capitalization is calculated as current share price multiplied by total shares outstanding; it is one of several measures of a company's size and is the primary factor used to assign stocks to size-based indices like the S&P 500 (large-cap) or Russell 2000 (small-cap).
Where can I see AbbVie Inc.'s SEC filings?
Every SEC filing made by AbbVie Inc. — annual reports (10-K), quarterly reports (10-Q), proxy statements, and material event filings (8-K) — is available free of charge on the SEC's EDGAR system at sec.gov/edgar. EDGAR is the authoritative source for public-company disclosures and the official venue for verifying any claim made by company executives in press releases or earnings calls.
Is the data on this page real-time?
No. Stock data on ExecBolt is sourced from Yahoo Finance and is delayed by 15 to 20 minutes for U.S. equities. For real-time quotes, use a brokerage account or a paid market-data subscription. The information here is intended for informational and analytical use, not active trading.
Does ExecBolt provide investment recommendations on ABBV?
No. This page presents factual data — price, volume, market cap, 52-week range, price history — and brief contextual notes about how to read those data points. ExecBolt does not provide investment advice, recommendations, or solicitations to buy or sell any security. Past performance does not guarantee future results, and any investment decision should be made in consultation with a qualified financial advisor.